Validation of a high performance functional assay for individual radiosensitivity in pediatric oncology: a prospective cohort study (ARPEGE)

Validation of a high performance functional assay for individual radiosensitivity in pediatric oncology: a prospective cohort study (ARPEGE)

Abstract Background Approximately 900 children/adolescents are treated with radiotherapy (RT) every year in France. However, among the 80% of survivors, the cumulative incidence of long-term morbidity – including second malignancies - reach 73.4% thirty years after the cancer diagnosis. Identifying...

Full description

Bibliographic Details
Main Authors: Valérie Bernier-chastagner, Liza Hettal, Véronique Gillon, Laurinda Fernandes, Cécile Huin-schohn, Marion Vazel, Priscillia Tosti, Julia Salleron, Aurélie François, Elise Cérimèle, Sandrine Perreira, Didier Peiffert, Pascal Chastagner, Guillaume Vogin
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Cancer
Subjects:
Pediatric oncology
Radiotherapy
Radiosensitivity
Toxicity
Biomarker
Predictive assay
Online Access:http://link.springer.com/article/10.1186/s12885-018-4652-7

Internet

http://link.springer.com/article/10.1186/s12885-018-4652-7

Similar Items